clasto-lactacystin beta-lactone has been researched along with aminolevulinic acid in 1 studies
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
Studies (clasto-lactacystin beta-lactone) | Trials (clasto-lactacystin beta-lactone) | Recent Studies (post-2010) (clasto-lactacystin beta-lactone) | Studies (aminolevulinic acid) | Trials (aminolevulinic acid) | Recent Studies (post-2010) (aminolevulinic acid) |
---|---|---|---|---|---|
85 | 0 | 15 | 6,475 | 665 | 2,740 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenbaum, L; Grinblat, B; Grünberg-Etkovitz, N; Malik, Z | 1 |
1 other study(ies) available for clasto-lactacystin beta-lactone and aminolevulinic acid
Article | Year |
---|---|
Proteasomal degradation regulates expression of porphobilinogen deaminase (PBGD) mutants of acute intermittent porphyria.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Nucleus; Cysteine Proteinase Inhibitors; Cytoplasm; Gene Expression Regulation; Hemin; Humans; Hydroxymethylbilane Synthase; Lactones; Lead Poisoning; Mutant Proteins; Neuroblastoma; Porphyria, Acute Intermittent; Proteasome Endopeptidase Complex; RNA, Messenger; Transfection | 2006 |